LIGAND PHARM Financial Diagnostics

LGNZZ -- USA Stock  

USD 0.15  0.01  0.07%

Macroaxis technical analysis interface lets you check helpful technical drivers of LIGAND PHARM INC as well as the relationship between them. The company directors and management were quite successful positioning the firm components to exploit market volatility in February 2019. The stock standard deviation of daily returns for 30 days (very short) investing horizon is currently 12.1555. The very high volatility is mostly attributed to the latest market swings and not very good earning reports from some ot the LIGAND PHARM INC partners. This diagnostics interface makes it easy to digest most current publicly released information about LIGAND PHARM as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis LIGAND PHARM price relationship with some important fundamental indicators such as market cap and management efficiency. Please see also Stocks Correlation.

LIGAND PHARM Note

The company had not issued any dividends in recent years.

LIGAND PHARM INC Alerts

LIGAND PHARM INC is not yet fully synchronised with the market data
LIGAND PHARM INC appears to be very risky and stock price may revert if volatility continues
LIGAND PHARM INC has some characteristics of a very speculative penny stock

LIGAND PHARM Predictive Indicators

Did you try this?

Run Analyst Recommendations Now

   

Analyst Recommendations

Analyst recommendations and target price estimates broken down by several categories
All  Next Launch Analyst Recommendations

Also Currentnly Active

Purchased few shares of
few days ago
Traded for 0.52
Purchased over 90 shares of
few days ago
Traded for 0.13
Purchased few shares of
few days ago
Traded for 0.24
Please see also Stocks Correlation. Please also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Search macroaxis.com